Pharma & Bio
Technology
Lotte Bio Faces Fears of Massive Depreciation at Songdo Plant... Desperately Needs to Secure Contracts by Year-End
Lotte Biologics has completed its Songdo Bio Campus Plant No. 1 after investing approximately 1.4 trillion won, but the company now finds itself in a position where it must bear massive fixed costs wi…
Lifestyle
Obesity and Diabetes Stocks Rally Sharply as Quratis and MFC Hit Daily Limit Gains [K-Bio Pulse]
As glucagon-like peptide-1 (GLP-1) therapies for obesity and diabetes establish themselves as a major trend in the global pharmaceutical and biotech sectors, strong buying momentum is driving interest…
Lifestyle
Obesity and Diabetes Treatment-Themed Stocks on the Rise… Quratis Inc. and MFC Co., Ltd. Hit Daily Price Limits [Bio Spotlight]
As glucagon-like peptide-1 (GLP-1) class obesity and diabetes treatments have established themselves as a major trend in the global pharmaceutical and biotech markets, strong buying momentum is gather…
Technology
“The Era of At-Home Cancer Treatment”… Why Herings and KGOG Are Developing a Gynecological Cancer Monitoring Platform
The focus of cancer treatment is shifting from hospital injection rooms to patients’ daily lives. This shift is driven by global pharmaceutical companies converting intravenous (IV) biologics—which us…
Technology
1,500 Doctors Specializing in Clinical Trials in the U.S., 24 in South Korea… A Shortage of Medical Personnel
“While it was certain that the U.S. Food and Drug Administration (FDA) would respond within 30 days, I got the impression that the review process at the Ministry of Food and Drug Safety (MFDS) had a r…
Technology
“No Reform, No New Korean Drugs”… The MFDS’s IND Review in Light of the Kim Seung-won Incident
Kim Seung-won, nominee for Minister of Justice, delivers opening remarks during his confirmation hearing held on the 15th at the National Assembly’s Legislation and Judiciary Committee in Yeouido, Seo…
Lifestyle
G2G Bio and ImmuneOncia Rally, ABL Bio Tumbles Amid Insider Trading Probe [K-Bio Pulse]
G2G Bio and ImmuneOncia posted notable gains on Monday, while ABL Bio shares tumbled. G2G Bio rose more than 10% on expectations that competition among long-acting injectable technologies in the globa…
Lifestyle
G2GBIO, Inc. and ImmuneOncia Therapeutics, Inc. Soar, While ABL Bio Inc. Plummets Amid ‘Insider Trading Allegations’ [Bio Market Watch]
While #G2GBIO, Inc. and #ImmuneOncia Therapeutics, Inc. posted notable gains, ABL Bio Inc.(298380)plummeted. G2GBIO, Inc. rose more than 10% on expectations that the global obesity treatment market wi…
Technology
SK Biopharm: A Closer Look at the Opakalim Royalty Structure... Double Royalties and a Burden of Up to 28%
Attention is focusing on the dual royalty structure after #SK Biopharm—which licensed the new epilepsy drug candidate “Opacalym” (BHV-7000) from U.S. biotech firm Biohaven—agreed to pay royalties to t…
Lifestyle
INFINITT Healthcare Hits Daily Limit Up on Dividend Announcement; Samik Pharma Jumps [K-bio pulse]
South Korean healthcare stocks were mixed on Monday as investors reacted to dividend plans, patent developments, and expectations for overseas sales.INFINITT Healthcare hit its daily trading limit aft…